Neurovascular Surgery pp 365-370 | Cite as
Recognition of Minute (5 mm) Cerebral Gliomas by Advanced Computer Technology
Conference paper
Abstract
The treatment of primary brain tumors is usually unsuccessful. Great effort has been made to improve the statistics, but results have added only slight prolongation of life and some temporary amelioration of symptoms with essentially no cures. Tumors are found too late and too large. They resist complete removal and do not respond favorably to irradiation, chemotherapy, or immunologic attack (6).
Keywords
Tumor Removal Primary Brain Tumor Residual Cell Cerebral Glioma Residual Tumor Mass
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Preview
Unable to display preview. Download preview PDF.
References
- 1.FUDENBERG, H.H., STITES, D.P., CALDWELL, J.L., WELLS, J.V. (eds.): Basic and clinical immunology. Lange 1976Google Scholar
- 2.GRUBB, R.L.: Emission computed tomography. Neurosurgery 2, 273–280 (1978)PubMedCrossRefGoogle Scholar
- 3.HOOD, L.: Personal communication, California Institute of Technology, October 1978Google Scholar
- 4.MORANTZ, R.A., SHAIN, W., CRAVIOTO, H.: Immune surveillance and tumors of the nervous system. J. Neurosurg. 49, 84–92 (1978)PubMedCrossRefGoogle Scholar
- 5.OMMAYA, A.K.: Immunotherapy of gliomas: A review. Adv. Neurol. 15, 337–359 (1976)PubMedGoogle Scholar
- 6.SHAPIRO, W.R., YOUNG, D.F.: Treatment of malignant glioma. Arch. Neurol. 33, 494–500 (1976)PubMedGoogle Scholar
- 7.TAKAKURA, K., MIKI, Y., KUBO, O., OGAWA, W., MATSUTANT, M., SANO, K. : Adjuvant immunotherapy for malignant brain tumors. Jap. J. Clin. Oncol. 12, 109–120 (1972)Google Scholar
- 8.TROUILLAS, P. : Letter: Carcino-fetal antigen in glial tumors. Lancet 11, 52 (1971)CrossRefGoogle Scholar
Copyright information
© Springer-Verlag Berlin Heidelberg 1979